Progen (ASX:PGL) announced today that their lead anti-angiogenesis product (PI-88) has received Orphan Drug designation from the US FDA.
Will be interesting to see the effect on Solbec & chances of gaining orphan drug status also.
- Forums
- ASX - By Stock
- SBP
- progen granted orphan drug status
SBP
solbec pharmaceuticals limited
progen granted orphan drug status
-
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)